|Videos|October 26, 2017

Adults Aged 65 and Older Need to Get Their Flu Shots: Here's Why

William Schaffner, MD, explains why adults aged 65 and older need to receive the flu shot.

William Schaffner, MD, medical director of the National Foundation for Infectious Diseases, explains why adults aged 65 and older need to receive the flu shot.

Interview Transcript (modified slightly for readability):

"We vaccinate two-thirds of the people in the United States who are aged 65 and older each year, and that’s a terrific achievement, but think about it: that means one-third of the population, 15 million people who are 65 and older still do not avail themselves of vaccination. We have to do better as providers, and I hope we can motivate those individuals to come in and request influenza immunization.

You know, people aged 65 and older have a diminished immune system. It doesn’t work as well; it’s not as responsive as the immune system in younger people, and so, they are disproportionately made ill, they get more serious illness when they’re infected with influenza.

On top of that, people aged 65 and older begin to accumulate a number of chronic illnesses—heart disease, diabetes, lung disease, asthma—and that makes the impact of flu even more serious because all of those chronic illnesses predispose to pneumonia and other serious complications of influenza."


Related to this article

REMAP-CAP and the Tamiflu “Pre-Release”: A Set-Up for Disaster
Preliminary REMAP-CAP data suggesting oseltamivir may increase mortality in critically ill ICU influenza patients has sparked polarized reactions, but clinicians should await the full peer-reviewed manuscript before drawing broad conclusions, since the signal comes from a narrow, severely ill population and may reflect a therapeutic window effect rather than a blanket lack of efficacy.
GSK's mRNA Influenza Vaccine Moves to Phase 3 Trial
GSK will advance its investigational mRNA seasonal flu vaccine candidate, which targets both hemagglutinin and neuraminidase, into a phase 3 trial in September 2026 after the shot outperformed licensed flu vaccines in a phase 2 study.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.